Seebri and Leukopenia - a phase IV clinical study of FDA data

Summary:

Leukopenia is reported as a side effect among people who take Seebri (glycopyrrolate), especially for people who are female, 60+ old, also take Abraxane, and have Chronic obstructive pulmonary disease.

The phase IV clinical study analyzes which people have Leukopenia when taking Seebri. It is created by eHealthMe based on reports of 2,613 people who have side effects when taking Seebri from the FDA, and is updated regularly.

What is Seebri?

Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.

What is Leukopenia?

Leukopenia (less number of white blood cells in blood) is found to be associated with 1,681 drugs and 2,289 conditions by eHealthMe. Check the latest studies of Leukopenia.

On Jul, 20, 2026

2,613 people reported to have side effects when taking Seebri.
Among them, 18 people (0.69%) have Leukopenia.

Among these 18 people:

What is the gender of people who have Leukopenia when taking Seebri? *

female: 70.59 %
male: 29.41 %

What is the age of people who have Leukopenia when taking Seebri? *

What are other drugs people take besides Seebri? *

What are other side effects people have besides Leukopenia? *

Thrombocytopenia (decrease of platelets in blood): 16 people, 88.89%
Infection: 7 people, 38.89%
Dizziness: 7 people, 38.89%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 33.33%
Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used): 5 people, 27.78%
Anaemia (lack of blood): 4 people, 22.22%
Pneumonia: 2 people, 11.11%
Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 2 people, 11.11%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 11.11%
Hypokalemia (low potassium): 2 people, 11.11%

What are the existing conditions these people have? *

Selenium Deficiency (lack of selenium): 9 people, 50.00%
Rickets (softening of bones): 9 people, 50.00%
Lung Cancer - Non-Small Cell (lung cancer): 9 people, 50.00%
Depression: 9 people, 50.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 9 people, 50.00%
Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 7 people, 38.89%
Pain: 4 people, 22.22%
Pneumonia: 3 people, 16.67%
Diarrhea: 2 people, 11.11%
Breast Cancer Metastatic: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Seebri and have Leukopenia?

- Check whether Leukopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Seebri:

Seebri (2,618 reports)

Leukopenia treatments and more:

Leukopenia (58,665 reports)

Browse all side effects of Seebri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Leukopenia:

Leukopenia (1,682 drugs)

Browse all the conditions that are associated with Leukopenia:

Leukopenia (2,289 conditions)

Related publications that referenced our studies

D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Seebri) and Seebri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.